⚖️ High Court Trial-at-Bar Scrutinizes Crisis-Era Medicine Procurement Scandal

The high-profile substandard medicine case involving former Health Minister Keheliya Rambukwella and senior officials has shifted to the Colombo High Court Trial-at-Bar, moving from public spectacle to strict legal scrutiny. • Overall Figures & Charges: The prosecution alleges the fraudulent misuse of over Rs. 144 million in public funds. The state claims normal procurement protocols were bypassed during the 2022–2023 economic crisis to import substandard Human Immunoglobulin and Rituximab stocks, with lab reports alleging bacterial contamination and saline substitution. • The Core Legal Dilemma: The case highlights the tension between emergency administrative decision-making and criminal accountability. The defense argues that pharmaceutical procurement committees do not manufacture or independently test drugs, and cannot be held criminally liable for a supplier's subsequent quality failure without proof of deliberate collusion, kickbacks, or intent. • Crisis Context & Impact: Testimony has underscored that the procurement occurred during Sri Lanka's worst economic collapse, characterized by severe foreign exchange shortages, delayed Letters of Credit, and collapsing hospital supplies. Analysts note the trial could redefine how criminal liability is assessed in public procurement during national emergencies, exposing systemic vulnerabilities in the country's healthcare regulatory mechanisms.